GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Equity-to-Asset

Moogene Medi Co (XKRX:322970) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Moogene Medi Co's Total Stockholders Equity for the quarter that ended in . 20 was ₩0.00 Mil. Moogene Medi Co's Total Assets for the quarter that ended in . 20 was ₩0.00 Mil.

The historical rank and industry rank for Moogene Medi Co's Equity-to-Asset or its related term are showing as below:

XKRX:322970's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.68
* Ranked among companies with meaningful Equity-to-Asset only.

Moogene Medi Co Equity-to-Asset Historical Data

The historical data trend for Moogene Medi Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Equity-to-Asset Chart

Moogene Medi Co Annual Data
Trend
Equity-to-Asset

Moogene Medi Co Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Moogene Medi Co's Equity-to-Asset

For the Biotechnology subindustry, Moogene Medi Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moogene Medi Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moogene Medi Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Moogene Medi Co's Equity-to-Asset falls into.


;
;

Moogene Medi Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Moogene Medi Co's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Moogene Medi Co's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moogene Medi Co  (XKRX:322970) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Moogene Medi Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Moogene Medi Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Moogene Medi Co Business Description

Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines